Turnstone Biologics Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Turnstone Biologics Corp. generated cash of -$66,152,000, which is more than the previous year. Cash used in financing activities reached the amount of $77,046,000 last year. Net change in cash is therefore -$17,199,000.
Cash Flow
| 2021 | -45.62M | -3.34M | 79.95M |
|---|---|---|---|
| 2022 | -71.06M | -14.93M | -2.65M |
| 2023 | -66.15M | -28.09M | 77.04M |
TSBX Cash Flow Statement (2021 – 2023)
| 2023 | 2022 | 2021 | |
|---|---|---|---|
Cash at beginning of period | 35.11M | 123.76M | 92.78M |
Operating activities | |||
Net income | -55.2M | -30.83M | 33.26M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 2.79M | 3.90M | 1.39M |
Stock-based compensation expense | 4.21M | 6.41M | 2.61M |
| Deferred income tax benefit | 4.21M | 6.41M | 2.61M |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 8.53M | -2.01M | -2.36M |
Inventories | 0 | -6.26M | 705K |
Accounts payable | -3.39M | 3.40M | -2.15M |
Cash generated by operating activities | -66.15M | -71.06M | -45.62M |
Investing activities | |||
Purchases Of Investments | -109.79M | -59.51M | -41.38M |
Investments In Property Plant And Equipment | -1.24M | -5.17M | -3.40M |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -28.09M | -14.93M | -3.34M |
Financing activities | |||
Common Stock Issued | 77.83M | 157K | 0 |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 |
Cash used in financing activities | 77.04M | -2.65M | 79.95M |
Net Change In Cash | -17.19M | -88.65M | 30.97M |
Cash at end of period | 17.91M | 35.11M | 123.76M |
| Data source |